Wednesday May 15
Synta Announces Presentations at the 2013 American Society for...
Synta Pharmaceuticals Corp. today announced scheduled presentations at the 2013 American Society for Clinical Oncology Annual Meeting, which is taking place May 31 - June 4 in Chicago.
Synta Pharmaceuticals Lowered to "Market Perform" at BMO Capital Markets
Several other analysts have also recently commented on the stock. Analysts at Roth Capital raised their price target on shares of Synta Pharmaceuticals from $16.00 to $18.00 in a research note to investors on Wednesday, May 1st.
Synta Provides Clinical Updates and Reports First Quarter 2013 Financial Results
Synta Pharmaceuticals Corp. today provided clinical updates and reported financial results for the first quarter ended March 31, 2013.
Wall St. Cheat Sheet
Synta Pharmaceuticals Earnings Preview: Get Ahead of the Analysts
Synta Pharmaceuticals will report earnings before markets open on Tuesday, April 30th.